Home Blog Page 3

Nestlé India Meeting with Institutional Investors Scheduled for December 2, 2025

Nestlé India has announced a meeting with institutional investors and analysts scheduled for December 2, 2025, at 4:00 P.M. (IST) in Mumbai. The purpose of the meeting is to discuss company performance and strategy. This event demonstrates Nestlé’s commitment to engaging with its investor base and providing updates on its business outlook. More information is available on Nestlé India’s website.

Institutional Investor Engagement

Nestlé India will host a meeting with a group of institutional investors and analysts in Mumbai on December 2, 2025. The meeting is scheduled to commence at 4:00 P.M. (IST).

Meeting Details

The scheduled meeting provides an opportunity for institutional investors and analysts to gain insights into Nestlé India’s current strategies. This will provide a chance to interact with the company’s management. Further details may be available on the company’s website, www.nestle.in.

Source: BSE

Dr. Reddy’s Aurigene Oncology Faces GST Penalty of ₹64.9 Lakhs

Aurigene Oncology Limited, a subsidiary of Dr. Reddy’s Laboratories, has received an order from the GST Appellate Authority regarding a tax demand, including a penalty. The penalty amounts to ₹64,94,862. The order, received on November 25, 2025, relates to a dispute over tax liability. The company is evaluating its options for filing an appeal.

GST Penalty Imposed

Aurigene Oncology Limited has received an order from the GST Appellate Authority, leading to a penalty of ₹64,94,862. This matter pertains to a disagreement concerning tax obligations, as detailed in the official communication received by the company on November 25, 2025.

Details of the Order

The order stems from an appeal filed by Aurigene Oncology, which was subsequently dismissed on May 24, 2024. The appeal sought to challenge a demand, including a penalty levied under the relevant GST Acts from 2017. The core issue involves the authority’s claim that Aurigene incorrectly declared its tax liability when filing its annual GSTR-09 returns. The official notification of the order was delivered to the company via email.

Company’s Response

Dr. Reddy’s Laboratories is currently assessing the situation and determining the next steps, which includes evaluating the possibility of filing a further appeal with the appropriate appellate authority. According to their internal evaluation, the company believes that this penalty will not have a material impact on its financials, operations, or other activities.

Source: BSE

Union Bank of India Timely Payment of Annual Interest on Bonds

Union Bank of India confirms the timely payment of annual interest on its bonds as of November 26, 2025. The interest payment, amounting to ₹71,80,00,000/-, has been made to investors. The record date for determining beneficiary positions was also successfully managed. This announcement reinforces the bank’s commitment to fulfilling its financial obligations.

Annual Bond Interest Payment

Union Bank of India has announced the timely payment of annual interest on its bonds, confirming its dedication to its investors and financial responsibilities. The interest was paid on November 26, 2025.

Key Details of the Interest Payment

Here are the key details regarding the interest payment:

* ISIN: INE692A08102
* Issue Size: ₹ 1,000 Crores
* Interest Amount: ₹ 71,80,00,000/-
* Frequency: Yearly
* Interest Payment Record Date: 11.11.2025
* Due Date: 26.11.2025
* Actual Date of Payment: 26.11.2025
* Date of Last Interest Payment: 26.11.2024

The amount of interest paid was ₹71,80,00,000/-. The payment was made on the due date, November 26, 2025.

Source: BSE

Oberoi Realty Enters Development Agreement for Nepean Sea Road Redevelopment

Oberoi Realty has entered into a Development Agreement for the redevelopment of land admeasuring 4,706 square meters on Nepean Sea Road, Mumbai. The project’s free sale component is estimated to be around 1.18 lakh square feet (RERA Carpet area). This development aligns with the company’s strategy to expand its presence in prime locations and cater to the luxury residential market.

Nepean Sea Road Project

Oberoi Realty has finalized a Development Agreement concerning a prime property located on Nepean Sea Road in Mumbai. The land parcel, covering approximately 4,706 square meters, is slated for redevelopment, marking a significant addition to the company’s portfolio.

Projected Saleable Area

The project is expected to yield a free sale component of around 1.18 lakh square feet based on RERA Carpet area. This calculation remains subject to the provisions of the Development Control & Promotion Regulations for Greater Mumbai, 2034, and other applicable laws. The agreement, announced on November 26, 2025, signifies Oberoi Realty’s continued focus on luxury developments in strategic locations.

Source: BSE

Union Bank of India Penalty Imposed by Reserve Bank of India

Union Bank of India has been penalized by the Reserve Bank of India (RBI) with a fine of ₹8,43,000.00. The penalty was levied due to deficiencies observed in the handling of soiled note remittances to the RBI and issues related to ATM cash management. The bank has taken necessary steps to prevent similar issues from happening in the future.

Penalty from Reserve Bank of India

Union Bank of India has received a penalty from the Reserve Bank of India amounting to ₹8,43,000.00. This penalty was imposed due to certain operational deficiencies identified by the regulatory authorities.

Reasons for the Penalty

The penalty stems from deficiencies observed in soiled notes remittances made to the RBI and irregularities in ATM cash out penalty.

Corrective Measures

The bank has initiated preventive actions to avoid a recurrence of such issues. The receipt date of the directive regarding the penalty was November 25, 2025. The impact on the bank’s overall financial operation is considered Not Significant.

Source: BSE

Schaeffler Special Window for Re-lodgement of Physical Share Transfer Requests

Schaeffler India has introduced a special window for shareholders to re-lodge requests for the transfer of physical shares. This initiative allows shareholders another opportunity to convert their physical shares into dematerialized form, enhancing convenience and security. The company has reposted details on its social media channels. The window aims to streamline the process, ensuring efficient handling of transfer requests. Date of announcement: 26/11/2025.

Re-lodgement Opportunity

Schaeffler India has announced a special window to facilitate the re-lodgement of transfer requests for physical shares. This initiative aims to assist shareholders in converting their physical share certificates into electronic (dematerialized) form, making the transfer process smoother and more secure.

Details of the Initiative

The company has reposted details on its social media channels. For more information, you can visit their Facebook page: Schaeffler India Facebook. Shareholders are encouraged to utilize this window to simplify and secure their shareholding process. The announcement was made on 26/11/2025.

Source: BSE

IndiaMART Allotment of Equity Shares Under Employee Stock Benefit Scheme 2018

IndiaMART InterMESH Limited has allotted 55,000 equity shares under its Employee Stock Benefit Scheme 2018. The shares, with a face value of ₹10 each, were allotted at ₹10 per share to the Indiamart Employee Benefit Trust. This allotment increases the company’s paid-up equity share capital from ₹60,03,21,480 to ₹60,08,71,480.

Equity Shares Allotment Details

On November 26, 2025, the Share Allotment Committee of IndiaMART InterMESH Limited approved the allotment of 55,000 equity shares. These shares were allotted under the Indiamart Employee Stock Benefit Scheme 2018.

Key Highlights of the Allotment

The allotted shares have a face value of ₹10 each and were issued at a price of ₹10 per share. This allotment was made to the Indiamart Employee Benefit Trust.

As a result of this allotment, the company’s paid-up equity share capital has increased from ₹60,03,21,480 (consisting of 6,00,32,148 equity shares) to ₹60,08,71,480 (consisting of 6,00,87,148 equity shares).

Details of Shares Allotted

The allotted equity shares are fully paid up and rank pari-passu with the existing equity shares of the company. The distinctive numbers for these shares range from 6,14,42,149 to 6,14,97,148 (both inclusive), and the ISIN is INE933S01016.

Source: BSE

Nykaa Appoints Chetan Sharma as Company Secretary and Compliance Officer

Nykaa has appointed Chetan Sharma as the new Company Secretary and Compliance Officer, effective November 26, 2025. The appointment was made based on the recommendation of the Nomination and Remuneration Committee and approved by the Board of Directors. Sharma brings over 19 years of experience in Company Secretarial, Legal, Governance, and Compliance roles across various industries.

Key Leadership Appointment

Nykaa has announced the appointment of Chetan Sharma as the Company Secretary and Compliance Officer, effective November 26, 2025. This decision was made following the recommendation of the Nomination and Remuneration Committee and subsequently approved by the Board of Directors during their meeting held on November 26, 2025.

Chetan Sharma’s Background

Mr. Sharma brings over 19 years of diversified experience across Company Secretarial, Legal, Governance, and Compliance functions, spanning various industries. His experience includes roles in Pharmaceuticals, Automobiles, Manufacturing, IT, and Financial / Investment Banking Services. He previously served as the Group Company Secretary and Compliance Officer of the Emcure Pharmaceuticals Group, where he led several strategic initiatives, including an IPO and the establishment of a Group Compliance Framework.

Earlier in his career, Mr. Sharma held leadership positions with Varroc Engineering and Cadila Pharma Group, managing compliances, governance, legal affairs, and strategic initiatives. He also has experience in investment and merchant banking.

Qualifications and Expertise

Mr. Sharma is a qualified Company Secretary and Chartered Secretary. He holds degrees in LLB, LLM, M.Com, and MBA, along with an executive Leadership Certification from IIM, Ahmedabad, and a certification course on IPR from IIM, Bengaluru.

No Conflicts of Interest

Mr. Chetan Sharma is not related to any of the Directors or Promoters of the Company.

Source: BSE

Asian Paints New Paint Manufacturing Facility Set Up in UAE

Asian Paints announces the establishment of a second paint manufacturing facility in the United Arab Emirates (UAE) through its step-down subsidiary, Berger Paints Emirates Ltd Co (L.L.C). With an investment of AED 140 million (approximately INR 340 crores), the facility will have an initial capacity of 55,800 KL per annum and cover 100,000 sqm within Khalifa Economic Zones Abu Dhabi (KEZAD).

New Manufacturing Plant

Asian Paints has announced the setting up of a second paint manufacturing facility in the United Arab Emirates (‘UAE’). This expansion is through its step-down subsidiary, Berger Paints Emirates Ltd Co (L.L.C), UAE. This development signifies a strategic move to enhance its manufacturing capabilities in the region.

Investment and Capacity

The company is investing AED 140 million, which is approximately INR 340 crores, into this new facility. The plant is designed to have an initial production capacity of 55,800 KL per annum. The expansion will enable Asian Paints to better serve the growing demand in the UAE market.

Location and Size

The manufacturing facility will be spread across an area of 100,000 sqm. It will be located within the Khalifa Economic Zones Abu Dhabi (‘KEZAD’). This strategic location will provide logistical advantages and support the efficient operation of the new plant.

Date of Announcement

The announcement regarding the new manufacturing facility was made on 26th November 2025.

Source: BSE

Havells India Acquires 26% Stake in Kundan Solar for Green Energy Push

Havells India has approved acquiring a 26% stake in Kundan Solar (Pali) Private Limited for INR 5.63 Crores. This Special Purpose Vehicle (SPV) focuses on developing, installing, operating, and maintaining solar power plants. This investment will enable Havells to strategically reduce dependence on fossil fuels and save on power costs at Rajasthan plants. The solar plant is expected to be commissioned in Q2 FY26-27.

Strategic Investment in Solar Power

Havells India announced its investment into renewable energy through the acquisition of a 26% stake in Kundan Solar (Pali) Private Limited. This decision was made during a meeting held on November 26, 2025. This investment underscores Havells’ commitment to sustainable energy practices and optimizing operational costs.

Kundan Solar Overview

Kundan Solar, incorporated on April 3, 2025, operates as a Special Purpose Vehicle (SPV) under Kundan Green Energy Private Limited, itself a part of the Kundan Group. Its primary activity is developing, installing, operating, and maintaining solar power plants.

Deal Rationale

The investment into Kundan Solar is intended to reduce dependence on traditional fossil fuels. Kundan Solar will establish a 15 MWac solar power plant, and Havells intends to secure a long-term Power Purchase Agreement (PPA) for up to 25 years.

Financial Details and Timeline

The total investment value is INR 5.63 Crores, securing a 26% stake in Kundan Solar. The project is slated for completion by June 30, 2026, and commissioning is expected in Q2 FY26-27. Savings in power costs are projected at plant locations in Rajasthan, with payback anticipated within approximately 12-18 months from commissioning.

Regulatory Context

Havells is required to maintain a minimum of 26% shareholding in the solar entity to qualify as a captive consumer under electricity laws.

Source: BSE